Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

Annals of Oncology

Volumn 14, Issue 6, 2003, Pages 867-872

  Aparicio, Jorge ^a   García del Muro, Xavier ^b   Maroto, Pablo ^c   Paz Ares, Luis ^d   Alba, Emilio ^e   Saénz, Alberto ^f   Terrasa, Joserfa ^g   Barnadas, Agustí ^h   Almenar, Daniel ⁱ   Arranz, José A ^j   Sánchez, Miguel ^k   Fernández, Antonio ^l   Sastre, Javier ^m   Carles, Joan ⁿ   Dorca, Joan ^o   Gumà, Joseph ^p   Yuste, A L ^a   Germa J R ^b   Del Barco, Sonia ^q   Rodríguez, Alberto ^r   Barrajón, Enrique ^s   Bastús, Romà ^ac   Domínguez, Severina ^t   Crespo, Carmen ^u   López Brea, Marta ^v   Murias, Adolfo ^w   Gallardo, Enrique ^x   Martínez, Purificación ^y   Dorta, Francisco J ^z   Lomas, María ^aa   Colmenarejo, Antonio ^ab   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^k HOSPITAL DONOSTIA   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^m HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁿ HOSPITAL DEL MAR   (Spain)

^o HOSPITAL JOSEP TRUETA   (Spain)

^p HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^q HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^r J R Jiménez Hospital   (Spain)

^s Hospital General   (Spain)

^t HOSPITAL TXAGORRITXU   (Spain)

^u HOSPITAL RAMÓN Y CAJAL   (Spain)

^v HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^w HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^x HOSPITAL DE TERRASSA   (Spain)

^y HOSPITAL DE BASURTO   (Spain)

^z HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^aa HOSPITAL INFANTA CRISTINA   (Spain)

^ab Hospital del Aire   (Spain)

^ac NONE

more..

Author keywords

Adjuvant carboplatin; Prognostic factors; Stage I seminoma; Surveillance

Indexed keywords

ANTIEMETIC AGENT; CARBOPLATIN; CISPLATIN; DEXAMETHASONE; ETOPOSIDE; SEROTONIN ANTAGONIST;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FATIGUE; HEALTH CARE POLICY; HIGH RISK POPULATION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUTROPENIA; ORCHIECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; SEMINOMA; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORCHIECTOMY; POLICY MAKING; POPULATION SURVEILLANCE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; SEMINOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS;

EID: 0038012184     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg241     Document Type: Article

References (23)

1. Dearnaley DP, Huddart RA, Horwich A. Managing testicular cancer. Br Med J 2001; 322: 1583-1588.
2. Zagars GK. Management of stage I seminoma: radiotherapy. In Horwich A (ed.): Testicular Cancer: Investigation and Management, 2nd edition. London, UK: Chapman & Hall 1996; 99-121.
3. Warde P, Gospodarowicz MK, Panzarella T et al. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 1995; 13: 2255-2262.
4. Oliver RTD, Edmonds PM, Ong JYH et al. Pilot studies of two and one course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 1994; 29: 3-8.
5. Hermanek P, Sobin LH. UICC: TNM Classification of Malignant Tumours, 4th edition. Berlin, Germany: Springer 1987.
6. Germà-Lluch JR on behalf of the Spanish Germ-Cell Cancer Group (GG). Adjuvant treatment for stage I germ-cell testicular tumours: preliminary experience of the Spanish Germ-Cell Cancer Group. In Jones WG, Appleyard I, Harnden P, Joffe JK (eds): Germ Cell Tumours IV. London, UK: John Libbey 1998; 139-142.
7. Arranz JA, García del Muro X, Gumà J et al. E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience. Ann Oncol 2001; 12: 487-491.
8. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
10. Fossa SD, Aass N, Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 1989; 16: 383-389.
11. Bokemeyer C, Schmoll HJ. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 1995; 13: 283-292.
12. Chao CK, Lai PP, Michalski JM et al. Secondary malignancy among seminona patients treated with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1995; 33: 831-835.
13. Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol 1999; 17: 1146-1154.
14. von der Maase H, Specht L, Jacobsen GK et al. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 1993; 29A: 1931-1934.
15. Horwich A, Alsanjari N, A'Hern R et al. Surveillance following orchidectomy for stage I seminoma. Br J Cancer 1992; 65: 775-778.
16. Germà JR, Climent MA, Villavicencio H et al. Treatment of stage I testicular tumours. Br J Urol 1993; 71: 473-477.
17. Sharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996; 14: 2933-2939.
18. Dieckmann K-P, Brüggeboes B, Pichlmeier U et al. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology 2000; 55: 102-106.
19. Reiter WJ, Brodowicz T, Alavi S et al. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma. J Clin Oncol 2001; 19: 101-104.
20. Steiner H, Höltl L, Wirtenberger W et al. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study. Urology 2002; 60: 324-328.
21. Warde P, Gospodarowicz MK, Banerjee D et al. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 1997; 157: 1705-1710.
22. Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2OO2; 20: 4448-4452.
23. Hoeltl W, Kosak D, Pont J et al. Testicular cancer: prognostic implications of vascular invasion. J Urol 1987; 137: 683-685.